Elite Health Systems Inc. filed a Form 8-K on November 20, 2026, disclosing that its Board of Directors announced a private placement of common stock on November 16, 2026, targeting gross proceeds of between $500,000 and $4,000,000 at $0.60 per share.

Key Highlights

  • Offering range: The private placement is structured to raise a minimum of $500,000 and up to a maximum of $4,000,000 at a price per share of $0.60.
  • Bonus share provision: If the company raises at least $3,000,000, investors in a prior $0.95 per share financing will receive one additional share for every two shares purchased in that prior financing, at no additional cost.
  • Investor eligibility: All participants are required to be accredited investors; no general solicitation was used and no commissions were paid, according to the filing.
  • Regulatory exemption: The company stated it will rely on Section 4(a)(2) and/or Rule 506(b) of Regulation D under the Securities Act of 1933 and plans to file a Form D with the SEC within 15 days of the first sale date.
  • Proceeds intended use: The company stated it "presently intends to apply substantially all the net proceeds" toward development of Elite Health Plan, Inc., a wholly-owned subsidiary, and related operational activities.
  • Medicare Advantage enrollment: As of November 18, 2026, the Centers for Medicare and Medicaid Services had accepted 2,407 new member applications for Elite Health's Medicare Advantage plan during the current Annual Enrollment Period.

Elite Health Systems Private Placement Details and Subsidiary Update

According to the filing, Elite Health Systems Inc. (Commission File Number 000-26575), a Delaware corporation based in Ontario, California, commenced a private placement of its common stock on November 16, 2026. The offering is priced at $0.60 per share and seeks gross proceeds of at least $500,000, with a maximum of $4,000,000. The company disclosed that the securities registered under Section 12(b) of the Act are listed as "N/A," and the filing does not identify a ticker symbol on a national exchange in the registered-securities table.

The filing describes a conditional benefit for prior investors: should the private placement raise at least $3,000,000, holders who participated in a previous financing at $0.95 per share will receive one bonus share of common stock for every two shares they purchased in that earlier round, regardless of whether they participate in the current offering. The company anticipates completing an initial closing within approximately one month from commencement and expects to hold multiple closings.

Net proceeds are directed toward Elite Health Plan, Inc., described in the filing as a wholly-owned subsidiary "with a limited operating history" that "was formed in 2017 with the purpose of establishing a managed care organization that will operate as a Medicare Advantage plan for seniors." The filing also noted that as of November 18, 2026, CMS had accepted 2,407 new member applications during the current Annual Enrollment Period. The filing was signed by Prasad Jeereddi, Chairman and CEO, on November 20, 2026.

What Was Disclosed

Elite Health Systems Inc. disclosed the commencement of a private placement of common stock at $0.60 per share targeting up to $4,000,000 in gross proceeds, the terms of a bonus share provision for prior investors, intended use of proceeds for its Medicare Advantage subsidiary, and current enrollment figures.